当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析 - 现金流量表

福元医药

(601089)

  

流通市值:32.32亿  总市值:75.55亿
流通股本:2.05亿   总股本:4.80亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金826,072,528.163,205,113,243.452,355,663,328.721,588,767,312.46
收到的税费返还833,878.943,550,708.962,867,408.961,601,250
收到其他与经营活动有关的现金36,690,917.87100,475,262.8399,099,303.7967,625,865.94
经营活动现金流入的平衡项目0000
经营活动现金流入小计863,597,324.973,309,139,215.242,457,630,041.471,657,994,428.4
购买商品、接受劳务支付的现金173,857,616.94533,322,152.43459,479,455.38307,218,286.56
支付给职工以及为职工支付的现金209,135,042.33585,701,186.86443,705,353.85306,624,878.19
支付的各项税费82,891,307.12380,838,872.08307,568,170.63226,831,278.65
支付其他与经营活动有关的现金253,830,314.061,253,376,391.77832,772,494.64535,597,484.05
经营活动现金流出的平衡项目0000
经营活动现金流出小计719,714,280.452,753,238,603.142,043,525,474.51,376,271,927.45
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额143,883,044.52555,900,612.1414,104,566.97281,722,500.95
二、投资活动产生的现金流量:
取得投资收益收到的现金-2,418,589.042,418,589.042,411,342.46
处置固定资产、无形资产和其他长期资产收回的现金净额8,571,117.5520,088.62244,289209,545
收到的其他与投资活动有关的现金-388,617,800385,000,000380,000,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计8,571,117.5391,556,477.66387,662,878.04382,620,887.46
购建固定资产、无形资产和其他长期资产支付的现金99,900,685.86366,075,648.69260,770,221.26161,833,012.48
支付其他与投资活动有关的现金-411,137,581.92410,998,981.92380,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计99,900,685.86777,213,230.61671,769,203.18541,833,012.48
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-91,329,568.36-385,656,752.95-284,106,325.14-159,212,125.02
三、筹资活动产生的现金流量:
取得借款收到的现金39,900,00055,000,00055,000,00055,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计39,900,00055,000,00055,000,00055,000,000
偿还债务支付的现金45,000,00044,943,908.2242,471,954.1142,471,954.11
分配股利、利润或偿付利息支付的现金411,446.58194,595,180.13195,494,529.88193,529,149.94
支付其他与筹资活动有关的现金155,886,770.4922,143,732.3717,292,090.6811,686,333.59
筹资活动现金流出平衡项目0000
筹资活动现金流出小计201,298,217.07261,682,820.72255,258,574.67247,687,437.64
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-161,398,217.07-206,682,820.72-200,258,574.67-192,687,437.64
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-108,844,740.91-36,438,961.57-70,260,332.84-70,177,061.71
加:期初现金及现金等价物余额2,504,500,364.082,540,939,325.652,540,939,325.652,540,939,325.65
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,395,655,623.172,504,500,364.082,470,678,992.812,470,762,263.94
补充资料:
净利润-492,336,741.15-252,279,579.43
资产减值准备-13,686,141.29-2,782,930.91
固定资产和投资性房地产折旧-69,038,855.41-33,373,417.83
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-69,038,855.41-33,373,417.83
无形资产摊销-10,730,062.24-5,216,042.81
长期待摊费用摊销-7,026,484.03-3,506,931.99
处置固定资产、无形资产和其他长期资产的损失--225,870.16--31,742.63
固定资产报废损失-1,226,441.67-695,382.17
财务费用-5,369,590.54-2,803,404.8
投资损失--2,281,687.77--2,274,851.37
递延所得税-1,284,742-1,724,724.26
其中:递延所得税资产减少-1,912,438.88-236,582.14
递延所得税负债增加--627,696.88-1,488,142.12
存货的减少-17,992,228.67--2,631,038.15
经营性应收项目的减少--23,283,497.97-37,928,070.02
经营性应付项目的增加--49,357,397.54--57,277,506.97
其他--2,764,926.99--239,110.06
现金的期末余额-2,504,500,364.08-2,470,762,263.94
减:现金的期初余额-2,540,939,325.65-2,540,939,325.65
公告日期2024-04-242024-04-012023-10-272023-08-15
审计意见(境内)标准无保留意见
TOP↑